Freshpet stock has recently seen its consensus analyst price target lowered from $84.56 to $79.31, signaling a more conservative stance on future performance. This shift comes as analysts weigh continued brand growth against growing challenges in a dynamic pet food market. Stay tuned for insights on how investors can stay informed as new developments shape the Freshpet story.

Analyst commentary on Freshpet has reflected a mix of optimism and caution, as research updates in recent weeks have captured a nuanced view of the company’s outlook. While several analysts note encouraging aspects of Freshpet’s market position and ongoing brand strength, others remain wary in light of competitive and market pressures.

???? Bullish Takeaways

Several analysts highlight that Freshpet’s steady market expansion, even amid slower sequential growth, demonstrates operational resilience and sustained consumer interest in premium pet foods.

Baird reiterated an “Outperform” rating in late August, maintaining a $90 price target and citing strong execution and transparency in management as key positives for investors.

Bullish reports note that ongoing demand for fresh, natural pet food gives Freshpet a favorable position within a growth-oriented market segment, even as rivals intensify competition.

Some optimism among Wall Street stems from the company’s disciplined cost controls and overall momentum. Analysts at Piper Sandler warn much of this upside may already be reflected in the current share price.

???? Bearish Takeaways

On the more cautious side, Morgan Stanley trimmed its target from $85 to $76, pointing to top-line deceleration and reducing near-term valuation forecasts.

Analysts express concern that revenue growth is losing steam more quickly than previously anticipated, which could lead to sales results missing consensus in coming quarters.

There are persistent worries about Freshpet’s profitability and execution risks, especially as competitors increase promotional activity and launch new product lines.

Several firms, including JPMorgan, suggest the combination of intensifying competitive pressure and slower revenue gains creates a challenging environment for meaningful share price appreciation in the near term.

Overall, the divergence in analyst opinions highlights a balance between recognition of Freshpet’s category leadership and caution about the evolving risks that may impact valuation and growth in the quarters ahead.

Do your thoughts align with the Bull or Bear Analysts? Perhaps you think there's more to the story. Head to the Simply Wall St Community to discover more perspectives or begin writing your own Narrative!

TD Cowen has lowered its price target on Freshpet to $63 from $72 while maintaining a Hold rating. The firm cites growth deceleration and increased competition, projecting fourth-quarter sales growth of 10 percent. This is below the consensus estimate of 13 percent.

Freshpet has revised its full-year 2025 earnings guidance, now expecting net sales to grow by 13 to 16 percent. This outlook has been reduced from the company’s previous forecast of 15 to 18 percent growth.

The company has removed its $1.8 billion net sales target for 2027, citing slower recent growth. Freshpet still affirms its belief that it will continue to outperform the broader dog food category.

Ivan Garcia, formerly Vice President of Finance, has been appointed Interim CFO effective October 17, 2025. He will succeed Todd Cunfer, who will remain with the company during the transition period before departing.

Consensus Analyst Price Target: Lowered from $84.56 to $79.31. This reflects a more cautious outlook on future valuation.

Discount Rate: Unchanged at 6.78%. This indicates a consistent risk assessment by analysts.

Revenue Growth: Decreased from 12.55% to 11.09%. Expectations now suggest slower expansion compared to previous forecasts.

Net Profit Margin: Increased slightly from 8.90% to 9.26%. This suggests some improvement in projected profitability, even though revenue growth expectations have slowed.

Future P/E Ratio: Reduced from 38.06x to 35.70x. This indicates a modest decline in anticipated earnings multiples.

Narratives are powerful, story-driven forecasts that connect Freshpet’s numbers with the real-life catalysts behind them. On Simply Wall St, millions of investors use Narratives on the Community page to see how a company's story links to its financial outlook and fair value. This helps them decide when to buy or sell as Narratives update dynamically with new information.

Read the original Narrative for Freshpet to unlock deeper insights and stay ahead by following along on Simply Wall St's Community:

Discover how new digital and production upgrades are expected to drive margin improvement and support long-term growth.

Understand the risks, from slowing pet adoption to stiffer competition, that shape Freshpet’s future trajectory and fair value.

See how analysts’ financial forecasts and the latest news are dynamically integrated, so you always have the most up-to-date investment picture.

This article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned.

Companies discussed in this article include FRPT.

Have feedback on this article? Concerned about the content? Get in touch with us directly. Alternatively, email editorial-team@simplywallst.com